A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

• 

• 
  • The Journal
  • Editor-In-Chief
  • Editorial Calendar
  • Submissions
  • Advertising
  • Permissions & Reprints
  • Privacy Policy

• 
  • Subscribe
  • Renew
  • Prices
  • Free Sample

• 
  • View Shopping Cart
  • Back Issues
  • Articles
  • Library Archives
  • Compounding Theme Archives
  • Other Products

• 
  • Supplemental Content and Errata
  • Training and Education
  • IJPC-PCAB SOP Matrix
  • USP GAP Analysis
  • Compounders' Network List
  • Patient Information
  • Videos
  • Compounders' Resource Directory

• 

• 

PreScription: Pain!

Author(s):  Allen Loyd V Jr

Issue:  May/Jun 2008 - Pain Management
View All Articles in Issue

Abstract:  

Related Keywords: Loyd V. Allen, Jr, PhD, RPh, pain management, controlled substances, regulation, U.S. Drug Enforcement Agency

Related Categories: LEGAL, PAIN MANAGEMENT

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details)	Author	Issue	Page	View/Buy
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act	Pore R David	Nov/Dec 2012	446-450	Buy
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh	Allen Loyd V Jr	Nov/Dec 2003	449-450	Buy
PreScription: Pain!	Allen Loyd V Jr	May/Jun 2008	180	Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines	Allen Loyd V Jr	Jul/Aug 2016	351	View Sample
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs	Allen Loyd V Jr	Sep/Oct 2017	356	Buy
Documentation: Records and Reports	Akers Michael J	Sep/Oct 2017	373-380	Buy
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications	Gilbert John A	Sep/Oct 2009	400-403	Buy
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA	Cabaleiro Joe	Sep/Oct 2021	358-362	Buy
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1	Allen Loyd V Jr	Jul/Aug 2007	350-351	Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances	Miller David G	Jul/Aug 2015	303-305	Buy